Offenburg, Germany

Bernhard Neises

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Aventis Pharma Deutschland, Gmbh, Sanofi-A Ventis Deutschland Gmbh. Active years: 2000-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernhard Neises. Retrieved from https://idiyas.com/inventor/bernhard-neises-rot0ukkx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 197(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Bernhard Neises

Introduction

Bernhard Neises is a notable inventor based in Offenburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 5 patents to his name, Neises has focused on developing compounds that address critical health issues.

Latest Patents

Among his latest patents, Neises has developed substituted indoles, which are compounds suitable for preparing pharmaceuticals aimed at the prophylaxis and therapy of disorders involving increased activity of NFκB. Additionally, he has worked on imidazolidine derivatives, detailing their production, uses, and the pharmaceutical preparations that contain them.

Career Highlights

Throughout his career, Neises has been associated with prominent companies in the pharmaceutical industry, including Aventis Pharma Deutschland GmbH and Sanofi-Aventis Deutschland GmbH. His work in these organizations has allowed him to contribute to the development of innovative medical solutions.

Collaborations

Neises has collaborated with several professionals in his field, including Hans Ulrich Stilz and Olaf Ritzeler. These partnerships have further enhanced his research and development efforts.

Conclusion

Bernhard Neises stands out as a significant figure in pharmaceutical innovation, with a focus on developing compounds that can lead to effective therapies. His contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…